| Literature DB >> 33722097 |
Mohamed Shawky Elfarargy1, Ghada M Al-Ashmawy2, Sally Abu-Risha3, Haidy Khattab4.
Abstract
Neonatal Respiratory Distress Syndrome (RDS) and Transient Tachypnea of newborn (TTN) are common similar neonatal respiratory diseases. Study the early predictor markers in differentiation between TTN and RDS in neonates. A prospective case control study which was done in Neonatal Intensive Care Unit (NICU) of Tanta University Hospital (TUH) from September 2016 to March 2018. Three groups of neonates were included in the study: RDS group (45 neonates), TTN group (45 neonates), and control group (45 healthy neonates). There were statistically significant difference (SSD) between our studied three groups as regard serum Malondialdehyde (MDA), Superoxide dismutase SOD, Lactate dehydrogenase (LDH), and blood PH and P-values were 0.001* for these comparative parameters. The ROC curve of RDS cases revealed that the serum MDA Cut off, sensitivity and specificity were 1.87 mmol/L, 98%, 96%, respectively which had the highest sensitivity and specificity followed by the serum SOD then the serum LDH and lastly the blood PH while in TTN cases, the serum MDA Cut off, sensitivity and specificity were 0.74 mmol/L, 96%, 93%, respectively then the serum SOD then the serum LDH and lastly the blood PH. Serum MDA, SOD, LDH, and PH had a beneficial role as early predictors in differentiation between TTN and RDS in neonates.Entities:
Keywords: differentiation; neonate; predictor; respiratory distress; tachypnea
Year: 2021 PMID: 33722097 PMCID: PMC7970176 DOI: 10.1177/20587384211000554
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219
Demographic data, APGAR score and time of sampling for the studied groups.
| RDS group (group 1)
( | TTN group (group 2)
( | Control group (group 3)
( | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % |
| |||
| Weight (kg) | Mean ± SD | 2.43 ± 0.21 | 2.57 ± 0.22 | 2.5 ± 0.21 | 1.357 | 0.185 | |||
| Gestational age (Week) | Mean ± SD | 35.9 ± 1.3 | 37.1 ± 1.1 | 37.2 ± 1.1 | 1.658 | 0.102 | |||
| APGAR score at 5 min | Median (IQR) | 7 (5–9) | 7 (5–9) | 9 (7–11) | KWχ2: 15.631 | 0.001 | |||
| Time of sampling (h) | Mean ± SD | 18.1 ± 3.1 | 18.1 ± 3.15 | 18.05 ± 3.05 | 0.652 | 0.864 | |||
| Sex | Male | 27 | 60 | 26 | 57.8 | 27 | 60 | 0.063 | 0.970 |
| Female | 18 | 40 | 19 | 42.1 | 18 | 40 | |||
P-value is significant if <0.05, f: ANOVA, KWχ2: Chi square for Kruskal Wallis test.
Serum LDH, MDA, and SOD and blood PH levels for the studied groups.
| RDS group (group 1) ( | TTN group (group 2) ( | Control group (group 3)
( | ||||
|---|---|---|---|---|---|---|
| Blood PH | Mean ± SD | 7.25 ± 0.06 | 7.32 ± 0.06 | 7.39 ± 0.05 | 11.527 | 0.001 |
| Serum LDH (IU/L) | Mean ± SD | 1112 ± 162 | 820 ± 121 | 424 ± 65 | 13.529 | 0.001 |
| Serum MDA (mmol/L) | Mean ± SD | 2.3 ± 0.5 | 1.3 ± 0.4 | 0.56 ± 0.2 | 9.834 | 0.001 |
| Serum SOD (U/ml) | Mean ± SD | 197.2 ± 21.1 | 234.7 ± 9.5 | 254.8 ± 18 | 8.691 | 0.001 |
P-value is significant if <0.05.
Blood PH and serum LDH, MDA, and SOD levels in neonates of group 1 according to the received treatment.
| Noninvasive ventilated cases
( | Invasive ventilated cases
( | ||||
|---|---|---|---|---|---|
| Blood PH | Mean ± SD | 7.27 ± 0.04 | 7.18 ± 0.01 | 4.958 | 0.001 |
| Serum LDH (IU/L) | Mean ± SD | 1050 ± 90 | 1220 ± 54 | 4.108 | 0.001 |
| Serum MDA (mmol/L) | Mean ± SD | 2.1 ± 0.2 | 2.55 ± 0.15 | 4.843 | 0.001 |
| Serum SOD (U/ml) | Mean ± SD | 213.4 ± 15 | 182.3 ± 7.1 | 4.537 | 0.001 |
P-value is significant if <0.05.
Correlation between serum MDA, SOD, and LDH and blood PH levels in neonates of group 1 and 2.
| Serum MDA (mmol/L) | ||||
|---|---|---|---|---|
| Group 1 | Group 2 | |||
|
|
|
|
| |
| Serum SOD (U/ml) | −0.444 | 0.002 | −0.595 | 0.001 |
| Serum LDH (IU/L) | 0.743 | 0.001 | 0.743 | 0.001 |
| Blood PH | −0.702 | 0.001 | −0.702 | 0.001 |
P-value is significant if <0.05.
Cut off value, sensitivity, specificity, PPV, NPV and accuracy of serum MDA, SOD and LDH, and blood PH levels in neonates of group 1 and 2.
| Cut off value | AUC | Sensitivity | Specificity | PPV | NPV | Accuracy | |
|---|---|---|---|---|---|---|---|
| Group 1 | |||||||
| Serum MDA (mmol/L) | 1.87 | 0.991 | 98 | 96 | 97 | 95 | 97 |
| Serum SOD (U/ml) | 226 | 0.973 | 96 | 94 | 95 | 92 | 94 |
| Serum LDH (IU/L) | 935 | 0.943 | 93 | 89 | 91 | 90 | 91 |
| Blood PH | 7.29 | 0.917 | 90 | 88 | 89 | 91 | 90 |
| Group 2 | |||||||
| Serum MDA (mmol/L) | 0.74 | 0.983 | 96 | 93 | 95 | 92 | 94 |
| Serum SOD (U/ml) | 240 | 0.962 | 93 | 90 | 92 | 91 | 92 |
| Serum LDH (IU/L) | 483 | 0.920 | 90 | 88 | 89 | 90 | 90 |
| PH | 7.36 | 0.897 | 88 | 84 | 87 | 86 | 87 |
Figure 1.(a, b) Showed the ROC Curve in group 1 and 2.